LEADER 01321cam0-22003851i-450- 001 990003297240403321 005 20100628111934.0 035 $a000329724 035 $aFED01000329724 035 $a(Aleph)000329724FED01 035 $a000329724 100 $a20030910d1986----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $aa-------001yy 200 1 $aPubblicazioni periodiche degli istituti di geografia delle università italiane$ein occasione del centenario dell'Istituto di geografia dell'Università di Napoli$fFernanda Montesano Berardelli 210 $aIstituto di geografia$cNapoli$d1986 215 $a189 p.$cill.$d24 cm 225 1 $aMemorie di geografia economica e antropica$iNuova serie$v15 610 0 $aGeografia$aPeriodici 676 $a021.015 700 1$aMontesano Berardelli,$bFernanda$0269683 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003297240403321 952 $a021.015.BER$fDECGE 952 $a021.069.BER$b7467$fDECGE 952 $aUB-C 006$bI.G.1937$fILFGE 952 $aCONS.2 UNINA.3(15)$bIst. s.i.$fILFGE 952 $aBER 021.015A$b19099$fDECBC 959 $aDECGE 959 $aILFGE 959 $aDECBC 996 $aPubblicazioni periodiche degli istituti di geografia delle università italiane$9445930 997 $aUNINA LEADER 05740nam 2200637Ia 450 001 9910777457503321 005 20200520144314.0 010 $a1-281-37805-4 010 $a9786611378059 010 $a0-387-71518-5 024 7 $a10.1007/978-0-387-71518-6 035 $a(CKB)1000000000440697 035 $a(EBL)371390 035 $a(OCoLC)272308574 035 $a(SSID)ssj0000103540 035 $a(PQKBManifestationID)11131344 035 $a(PQKBTitleCode)TC0000103540 035 $a(PQKBWorkID)10070357 035 $a(PQKB)10199630 035 $a(DE-He213)978-0-387-71518-6 035 $a(MiAaPQ)EBC371390 035 $a(Au-PeEL)EBL371390 035 $a(CaPaEBR)ebr10284529 035 $a(CaONFJC)MIL137805 035 $a(PPN)127046402 035 $a(EXLCZ)991000000000440697 100 $a20070423d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAngiogenesis$b[electronic resource] $ean integrative approach from science to medicine /$fedited by William D. Figg, Judah Folkman 205 $a1st ed. 2008. 210 $aNew York, NY $cSpringer$dc2008 215 $a1 online resource (616 p.) 300 $aDescription based upon print version of record. 311 $a1-4899-9668-0 311 $a0-387-71517-7 320 $aIncludes bibliographical references and index. 327 $aPhysiological & Pathological Angiogenesis: Biology of the Angiogenic Process -- History of Angiogenesis -- Angiogenesis and Vascular Remodeling in Inflammation and Cancer: Biology and Architecture of the Vasculature -- Endothelial Cell Activation -- Pericytes, the Mural Cells of the Microvascular System -- Matrix Metalloproteinases and Their Endogenous Inhibitors -- Integrins in Angiogenesis -- Angiogenesis and Regulatory Proteins -- Fibroblast Growth Factor-2 in Angiogenesis -- Vascular Permeability/Vascular Endothelial Growth Factor -- Platelet-Derived Growth Factor -- Angiopoietins and Tie Receptors -- Basement Membrane Derived Inhibitors of Angiogenesis -- Angiostatin and Endostatin: Angiogenesis Inhibitors in Blood and Stroma -- Thrombospondins: Endogenous Inhibitors of Angiogenesis -- Molecular & Cellular Mechanisms of the Angiogenic Process -- Overview of Angiogenesis During Tumor Growth -- Hypoxic Regulation of Angiogenesis by HIF-1 -- Regulation of Angiogenesis by von Hippel Lindau Protein and HIF2 -- Nitric Oxide in Tumor Angiogenesis -- VEGF Signal Tranduction in Angiogenesis -- Delta-like Ligand 4/Notch Pathway in Tumor Angiogenesis -- Immune Cells and Inflammatory Mediators as Regulators of Tumor Angiogenesis -- Contribution of Endothelial Progenitor Cells to the Angiogenic Process -- Tumor Angiogenesis and the Cancer Stem Cell Model -- Targeting the Tumor Microenvironment (Stroma) for Treatment of Metastasis -- Functional Assessments of Angiogenesis -- Normalization of Tumor Vasculature and Microenvironment -- Targeted Drug Delivery to the Tumor Neovasculature -- Models for Angiogenesis -- Surrogates for Clinical Development -- Imaging of Angiogenesis -- Tumor Endothelial Markers -- Clinical Translation of Angiogenesis Inhibitors -- Overview and Clinical Applications of VEGF-A -- Protein Tyrosine Kinase Inhibitors as Antiangiogenic Agents -- Therapeutic Strategies that Target the HIF System -- The Clinical Utility of Bevacizumab -- Development of Thalidomide and Its IMiD Derivatives -- TNP-470: The Resurrection of the First Synthetic Angiogenesis Inhibitor -- Clinical Development of VEGF Trap -- Recent Advances in Angiogenesis Drug Development -- Combination of Antiangiogenic Therapy with Other Anticancer Therapies -- Immunotherapy of Angiogenesis with DNA Vaccines -- Challenges of Antiangiogenic Therapy of Tumors -- Pharmacogenetics of Antiangiogenic Therapy -- Angiogenesis in Health & Disease -- Angiogenesis in the Central Nervous System -- Lymphatic Vascular System and Lymphangiogenesis -- Ocular Neovascularization -- Angiogenesis and Pathology in the Oral Cavity -- Revascularization of Wounds: The Oxygen-Hypoxia Paradox -- Journeys in Coronary Angiogenesis -- Perspectives on the Future of Angiogenesis Research. 330 $aDr. Judah Folkman, ?father of angiogenesis?, (1933-2008) was the Director of the Vascular Biology Program, Andrus Professor of Pediatric Surgery, and Professor of Cell Biology at Harvard University's Boston Children's Hospital. In the 1971 issue of The New England Journal of Medicine, he proposed the theory that tumor growth is angiogenesis dependent. This premise was the basis of this field of research and has become the focus of scientists worldwide. Because of Folkman's discovery and research, the possibilities of antiangiogenic and angiogenic therapy have broadened beyond cancer to many noncancerous diseases. This book represents the first collection in a volume of which Dr. Folkman is co-editor. Dr. Folkman authored nearly 400 original papers and more than 100 book chapters. Dr. William Figg is the chief of the Molecular and Clinical Pharmacology Program at the National Cancer Institute, National Institutes of Health. Over the past 15 years, his laboratory and clinic at the NCI have focused on the development of angiogenesis inhibitors. Dr. Figg has published more than 380 publications. 606 $aNeovascularization 606 $aBlood$xCirculation 615 0$aNeovascularization. 615 0$aBlood$xCirculation. 676 $a612.13 701 $aFigg$b William D$01547215 701 $aFolkman$b M. Judah$01547216 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910777457503321 996 $aAngiogenesis$93803428 997 $aUNINA